CN116018149A - 用于治疗呼吸障碍的干细胞 - Google Patents

用于治疗呼吸障碍的干细胞 Download PDF

Info

Publication number
CN116018149A
CN116018149A CN202180046236.7A CN202180046236A CN116018149A CN 116018149 A CN116018149 A CN 116018149A CN 202180046236 A CN202180046236 A CN 202180046236A CN 116018149 A CN116018149 A CN 116018149A
Authority
CN
China
Prior art keywords
composition
use according
mscs
disease
integrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180046236.7A
Other languages
English (en)
Chinese (zh)
Inventor
E·伦德格伦·阿克兰
S·林德施泰特
C·乌维布兰特
T·拉莫斯·莫雷诺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xintela AB
Original Assignee
Xintela AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xintela AB filed Critical Xintela AB
Publication of CN116018149A publication Critical patent/CN116018149A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transplantation (AREA)
CN202180046236.7A 2020-05-07 2021-05-07 用于治疗呼吸障碍的干细胞 Pending CN116018149A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20173592 2020-05-07
EP20173592.5 2020-05-07
PCT/EP2021/062111 WO2021224449A1 (en) 2020-05-07 2021-05-07 Stem cells for treatment of respiratory disorders

Publications (1)

Publication Number Publication Date
CN116018149A true CN116018149A (zh) 2023-04-25

Family

ID=70738255

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180046236.7A Pending CN116018149A (zh) 2020-05-07 2021-05-07 用于治疗呼吸障碍的干细胞

Country Status (11)

Country Link
US (1) US20230346843A1 (https=)
EP (1) EP4146234A1 (https=)
JP (1) JP7821414B2 (https=)
KR (1) KR20230008159A (https=)
CN (1) CN116018149A (https=)
AU (1) AU2021266603A1 (https=)
BR (1) BR112022022355A2 (https=)
CA (1) CA3177704A1 (https=)
IL (1) IL297902A (https=)
MX (1) MX2022013939A (https=)
WO (1) WO2021224449A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202103890D0 (en) * 2021-03-19 2021-05-05 Amniotics Ab Stem cells for use in reducing the immune response following organ transplantation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110234329A (zh) * 2017-01-27 2019-09-13 辛特拉股份公司 骨骼和软骨损害或疾病的预防和治疗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007099337A1 (en) * 2006-03-01 2007-09-07 Cartela R&D Ab Expansion and differentiation of mesenchymal stem cells
CN110177560A (zh) * 2016-12-28 2019-08-27 智再如股份有限公司 活体组织损伤的修复剂以及该修复剂的制造方法
CN116590227A (zh) * 2017-03-03 2023-08-15 日本乐敦制药株式会社 间充质干细胞和肝疾病治疗剂
WO2018159432A1 (ja) * 2017-03-03 2018-09-07 ロート製薬株式会社 間葉系幹細胞及び医薬組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110234329A (zh) * 2017-01-27 2019-09-13 辛特拉股份公司 骨骼和软骨损害或疾病的预防和治疗

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JIBIN HAN等: "Strategies to Enhance Mesenchymal Stem Cell-Based Therapies forAcute Respiratory Distress Syndrome", 《STEM CELLS INTERNATIONAL》, vol. 2019, 22 November 2019 (2019-11-22), pages 1 - 12 *

Also Published As

Publication number Publication date
BR112022022355A2 (pt) 2022-12-13
JP2023524150A (ja) 2023-06-08
MX2022013939A (es) 2023-02-09
CA3177704A1 (en) 2021-11-11
US20230346843A1 (en) 2023-11-02
JP7821414B2 (ja) 2026-02-27
EP4146234A1 (en) 2023-03-15
KR20230008159A (ko) 2023-01-13
WO2021224449A1 (en) 2021-11-11
AU2021266603A1 (en) 2022-12-08
IL297902A (en) 2023-01-01

Similar Documents

Publication Publication Date Title
Gonzales et al. The acute respiratory distress syndrome: mechanisms and perspective therapeutic approaches
Chou et al. Human mesenchymal stem cells attenuate experimental bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia
US20230310507A1 (en) Methods and compositions for treating lung conditions
JP6666395B2 (ja) 移植のための臓器の改良
US10723997B2 (en) Composition for treating chronic pulmonary disease, comprising exosome derived from thrombin-treated stem cell
Möbius et al. Prophylactic administration of mesenchymal stromal cells does not prevent arrested lung development in extremely premature-born non-human primates
JP7821414B2 (ja) 呼吸器疾患治療のための幹細胞
Li et al. Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis
Siavashi et al. The improvement of respiratory performance after phototherapy‐induced EPC mobilization in preterm infants with RDS
WO2014089397A1 (en) Compositions and methods of treating and preventing pulmonary fibrosis
CN117425724A (zh) 肿瘤缺氧驯化的再生巨噬细胞的获得方法及其在再生医学中的用途
US20200054684A1 (en) Non-mesenchymal human lung stem cells and methods of their use for treating respiratory diseases
Qi et al. Circulating CD34+ cells are elevated in neonates with respiratory distress syndrome
Jerzak et al. Diffuse alveolar haemorrhage--case report and literature review.
Wu et al. Wnt3a Enhances Mesenchymal Stem Cell Engraftment and Differentiation in a Chronic Obstructive Pulmonary Disease Rat Model
Birkett et al. Development of a novel humanized mouse model to study bronchopulmonary dysplasia
WO2024155791A1 (en) Use of umbilical vein endothelial cells for the treatment of lung injury
Hoang Stem Cell Therapy for Treatment of Bronchopulmonary Dysplasia
Moawed et al. Assessment of cord blood vascular endothelial growth factor levels and circulating CD34+ cells in preterm infants with respiratory distress syndrome
Horie Therapies for acute respiratory distress syndrome: determination of the mechanisms of action of hypercapnia and the therapeutic efficacy of mesenchymal stromal cells
HK1214130B (en) Improving organs for transplantation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination